US 12,226,318 B2
Implantable medical device
William Chase Harrington Parr, Tamarama (AU); and Ralph Jasper Mobbs, Coogee (AU)
Assigned to 3DMORPHIC PTY LTD, Matraville (AU)
Appl. No. 17/311,252
Filed by 3DMORPHIC PTY LTD, Matraville (AU)
PCT Filed Dec. 5, 2019, PCT No. PCT/AU2019/051332
§ 371(c)(1), (2) Date Jun. 4, 2021,
PCT Pub. No. WO2020/113276, PCT Pub. Date Jun. 11, 2020.
Claims priority of application No. 2018904650 (AU), filed on Dec. 6, 2018.
Prior Publication US 2022/0015918 A1, Jan. 20, 2022
Int. Cl. A61F 2/44 (2006.01); A61F 2/30 (2006.01)
CPC A61F 2/442 (2013.01) [A61F 2/30771 (2013.01); A61F 2/30942 (2013.01); A61F 2/4455 (2013.01); A61F 2002/30593 (2013.01); A61F 2002/30841 (2013.01); A61F 2002/30948 (2013.01); A61F 2002/30985 (2013.01)] 25 Claims
OG exemplary drawing
 
1. A corpectomy fusion component including:
a body having one or more surfaces with a contour formed to be substantially complementary to an anatomical surface of a specific patient;
the body adapted to securably engage with a component-engaging part such that the component-engaging part is configured to adjust from a first position to a second position, in a substantially linearly direction in order to adjust the height at least part of an implantable medical device,
wherein:
the one or more surfaces are substantially configured to evenly engage with the anatomical surface of the specific patient when the component is secured to the component-engaging part and the implantable medical device implanted in the patient; and
the body is at least in part manufactured by additive manufacturing.